Emergent role of gasotransmitters in ischemia-reperfusion injury

Medical Gas Research

Volumn 1, Issue 1, 2011, Pages

  Moody, Bridgette F ^a   Calvert, John W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

carbon monoxide; cytoprotection; hydrogen sulfide; ischemia reperfusion injury; Nitric oxide

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL PROTECTION; CHEMICAL ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; HEART MUSCLE CELL; LIPID PEROXIDATION; MICROCIRCULATION; MITOCHONDRIAL RESPIRATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; UBIQUITINATION; VASODILATATION;

EID: 84858081801     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-1-3     Document Type: Review

References (101)

1. Hydrogen sulfide and ischemia-reperfusion injury. Nicholson CK, Calvert JW, Pharmacol Res 2010 62 289 297 10.1016/j.phrs.2010.06.002 20542117
2. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Szabo C, Ischiropoulos H, Radi R, Nat Rev Drug Discov 2007 6 662 680 10.1038/nrd2222 17667957 (Pubitemid 47207751)
3. On the use of nitrite of amyl in angina pectoris. Brunton TL, 1867 2
4. The obligatory role dof endothelial cells in the relazation of arterial smooth muscle by acetylcholine. Furchgott RF, Zawadzki JV, 1980 288 288 373
5. Emerging role of carbon monoxide in physiologic and pathophysiologic states. Choi AM, Otterbein LE, Antioxid Redox Signal 2002 4 227 228 10.1089/152308602753666271 12006173 (Pubitemid 34517173)
6. Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. Wang R, Can J Physiol Pharmacol 1998 76 1 15 10.1139/y97-187 9564544 (Pubitemid 28201093)
7. Carbon monoxide: A putative neural messenger. Verma A, Hirsch D, Glatt C, Ronett G, Snyder S, Science 1993 259 381 384 10.1126/science.7678352 7678352 (Pubitemid 23055683)
8. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Ryter SW, Choi AM, Antioxid Redox Signal 2002 4 625 632 10.1089/15230860260220120 12230874 (Pubitemid 35001446)
9. Role of heme oxygenase-1 in cardiovascular function. Perrella MA, Yet SF, Curr Pharm Des 2003 9 2479 2487 10.2174/1381612033453776 14529547 (Pubitemid 37236367)
10. Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. Marshall HE, Stamler JS, Am J Respir Cell Mol Biol 1999 21 296 297 10460745 (Pubitemid 129517182)
11. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Foresti R, Motterlini R, Free Radic Res 1999 31 459 475 10.1080/10715769900301031 10630670
12. Hydrogen sulfide: its production, release and functions. Kimura H, J Neurosci 1996 16 1066 1071 8558235
13. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H, Antioxid Redox Signal 2009 11 703 714 10.1089/ars.2008.2253 18855522
14. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Hosoki R, Matsuki N, Kimura H, Biochem Biophys Res Commun 1997 237 527 531 10.1006/bbrc.1997.6878 9299397 (Pubitemid 27434718)
15. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. Zhao W, Zhang J, Lu Y, Wang R, EMBO J 2001 20 6008 6016 10.1093/emboj/20.21.6008 11689441 (Pubitemid 33049276)
16. The gasotransmitter role of hydrogen sulfide. Wang R, 2003 5 493 501
17. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. Bolli R, J Mol Cell Cardiol 2001 33 1897 1918 10.1006/jmcc.2001. 1462 11708836 (Pubitemid 33097270)
18. Nitric oxide and cardiovascular protection. Jugdutt B, Heart Fail Rev 2003 8 29 34 10.1023/A:1022190820131 12652157 (Pubitemid 36342288)
19. Nitric oxide, superoxide and peroxynitrite inmyocardial ischaemia-reperfusion injury and preconditioning. Ferdinandy P, Schulz R, Br J Pharmacol 2003 138 532 543 10.1038/sj.bjp.0705080 12598407 (Pubitemid 36315301)
20. Nitric oxide in myocardial ischemia/reperfusion injury. Schulz R, Kelm M, Heusch G, Cardiovasc Res 2004 61 402 413 10.1016/j.cardiores.2003.09.019 14962472 (Pubitemid 38210147)
21. The ubiquitous role of nitric oxide in cardioprotection. Jones SP, Bolli R, 2006 40 16 23
22. Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide. Bannenberg G, Vieira H, Expert Opin Ther Pat 2009 19 663 682 10.1517/13543770902858824 19441940
23. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model. Hannan RL, John MC, Kouretas PC, Hack BD, Matherne GP, Laubach VE, J Surg Res 2000 93 127 132 10.1006/jsre.2000.5953 10945953
24. Infarct size and nitric oxide synthase in murine myocardium. Sumeray MS, Rees DD, Yellon DM, J Mol Cell Cardiol 2000 32 35 42 10.1006/jmcc.1999.1050 10652188 (Pubitemid 30064302)
25. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Sharp BR, Jones SP, Rimmer DM, Lefer DJ, Am J Physiol Heart CIrc Physiol 2002 282 2422 2426 12003854
26. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D, Huang PL, Lefer DJ, Am J Physiol 1999 276 1567 1573 10330240
27. Inhibition of nitric oxide synthase by L-NAME speeds phase II pulmonary. VO2 kinetics in the transition to moderate-intensity exercise in man. Jones AM, Wilkerson DP, Koppo K, Wilmshurst S, Campbell IT, J Physiol 2003 552 265 272 10.1113/jphysiol.2003.045799 12897178 (Pubitemid 37265484)
28. Myocardial Reperfusion Injury: Insights Gained from Gene-Targeted Mice. Jones SP, Lefer DJ, News Physiol Sci 2000 15 303 308 11390931 (Pubitemid 33205101)
29. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Elrod JW, Greer JJ, Bryan NS, Langston W, Szot JF, Gebregzlabher H, Janssens S, Feelisch M, Lefer DJ, Arterioscler Thromb Vasc Biol 2006 26 1517 1523 10.1161/01.ATV.0000224324.52466.e6 16645153 (Pubitemid 44288977)
30. Endothelial nitric oxide synthatse overexpression attenuates myocardial reperfusion injury. Jones S, Greer J, Kakkar A, Ware P, Turnage R, Hicks M, vanHaperen R, de Crom R, Kawashima S, Yokoyama M, Lefer D, Am J Physiol Heart Cir Physiol 2004 286 276 282
31. Nitric oxide-dependent mechanism of anti-ischemic myocardial protection induced by monophosphoryl lipid A. Xi L, Zhongguo Yao Li Xue Bao 1999 20 865 871 11270982
32. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Liu X, Chapman G, Peyton K, Schafer A, Durante W, Cardiovasc Res 2002 55 396 405 10.1016/S0008-6363(02)00410-8 12123779 (Pubitemid 34775290)
33. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase. Burger DE, Xiang FL, Hammoud L, Jones DL, Feng Q, J Pharmacol Exp Ther 2009 329 900 907 10.1124/jpet.109.150896 19307451
34. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S, Casadei B, Circulation 2005 112 3729 3737 10.1161/CIRCULATIONAHA.105.539437 16344403 (Pubitemid 43739513)
35. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Li T, Li J, Liu J, Zhang P, Wu W, Zhou R, Li G, Zhang W, Yi M, Huang H, Free Radic Biol Med 2009 46 397 405 10.1016/j.freeradbiomed.2008.10.042 19038330
36. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R, Circulation 2007 116 1577 1584 10.1161/CIRCULATIONAHA.107.689810 17785622 (Pubitemid 47511421)
37. Inhaled nitric oxide attenuates apoptosis in ishemia-reperfusion injury of rabbit lungs. Yamashita H, Akamin S, Sumida Y, Inoue M, Sawada T, Nagayasu T, Oka T, The annals of thoracic surgery 78 292 297 204
38. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, et al. J Am Coll Cardiol 2007 50 808 817 10.1016/j.jacc.2007.04. 069 17707188 (Pubitemid 47243796)
39. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R, Circulation 1998 98 441 449 9714095 (Pubitemid 28357947)
40. Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN, Ping P, Am J Physiol Heart CIrc Physiol 2005 288 1290 1295 15528225
41. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Jha S, Calvert J, Duranski M, Ramachandran A, Lefer D, Am J Physiol Heart Circ Physiol 2008 295 801 806 10.1152/ajpheart.00377.2008 18567706
42. A crucial role for hydrogen sulfide in oxygen sensing via modulating large conductance calcium-activated potassium channels. Li Q, Sun B, Wang X, Jin Z, Zhou Y, Dong L, Jiang LH, Rong W, Antioxid Redox Signal 2010 12 1179 1189 10.1089/ars.2009.2926 19803741
43. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ, Circ Res 2009 105 365 374 10.1161/CIRCRESAHA.109.199919 19608979
44. A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury. Jones NC, Constantin D, Gibson CL, Prior MJ, Morris PG, Marsden CA, Murphy S, J Neuropathol Exp Neurol 2004 63 708 720 15290896 (Pubitemid 38891087)
45. Expression of heme oxygenase-1 in response to myocardial infarction in rats. Lakkisto P, Palojoki E, Backlund T, Saraste A, Tikkanen I, Voipio-Pulkki LM, Pulkki K, J Mol Cell Cardiol 2002 34 1357 1365 10.1006/jmcc.2002.2094 12392996 (Pubitemid 35244413)
46. Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Grilli A, De Lutiis MA, Patruno A, Speranza L, Gizzi F, Taccardi AA, Di Napoli P, De Caterina R, Conti P, Felaco M, Ann Clin Lab Sci 2003 33 208 215 12817626 (Pubitemid 36705932)
47. Cardioprotection and mechanisms of exogenous carbon monoxide releaser CORM-2 against ischemia/reperfusion injury in isolated rat hearts. Mei DS, Du YA, Wang Y, Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 36 291 297 17571314
48. Measuring left ventricular function in the normal, infarcted and CORM-3-preconditioned mouse heart using complex admittance-derived pressure volume loops. Clark JE, Kottam A, Motterlini R, Marber MS, J Pharmacol Toxicol Methods 2009 59 94 99 10.1016/j.vascn.2008.10.007 19059354
49. Ex vivo application of carbon monoxide in UW solutionprevents transplant-induced renal ischemia/reperfusion injury in pigs. Yoshida J, Ozaki K, Nalesnik M, Ueki S, Castillo-Rama M, Faleo G, Ezzelarab M, Nakao A, Ekser B, Echeverri G, et al. Am J Transplant 2010 10 763 772 10.1111/j.1600-6143.2010. 03040.x 20199500
50. Administration of a Co-releasing molecule at the time of reperfusion reduces infarct size in vivo. Guo Y, Stein A, Wu W, Tan W, Zhu X, Li Q, Dawn B, Motterlini R, Bolli R, Am J Physiol Heart Circ Physiol 2004 286 1649 1653 10.1152/ajpheart.00971.2003 14704226 (Pubitemid 38525450)
51. Hydrogen sulfide protects neurons from oxidative stress. Kimura Y, Kimura H, FASEB J 2004 18 1165 1167 15155563 (Pubitemid 39561558)
52. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P, Biochim Biophys Acta 2009 1787 864 872 10.1016/j.bbabio.2009.03.005 19285949
53. Signaling by gasotransmitters. Mustafa AK, Gadalla MM, Snyder SH, Sci Signal 2009 2 e2 10.1126/scisignal.268re2 19401594
54. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury - Evidence for a role of K ATP channels. Johansen D, Ytrehus K, Baxter GF, Basic Res Cardiol 2006 101 53 60 10.1007/s00395-005-0569- 9 16328106 (Pubitemid 43323432)
55. Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S). Elsey DJ, Fowkes RC, Baxter GF, Cell Biochem Funct 2010 28 95 106 10.1002/cbf.1618 20104507
56. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Hu Y, Chen X, Pan T, Neo K, Lee S, Khin E, Moore P, Bian J, Pflugers Arch 2008 455 607 616 17674030 (Pubitemid 350160475)
57. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. Bian JS, Yong Q, Pan T, Feng Z, Ali M, Zhou S, Moore P, J Pharmacol Exp Ther 2006 316 670 678 16204473 (Pubitemid 43130994)
58. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, et al. Proc Natl Acad Sci USA 2007 104 15560 15565 10.1073/pnas.0705891104 17878306 (Pubitemid 47502956)
59. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C, Shock 2009 31 267 274 10.1097/SHK.0b013e318180ff89 18636044
60. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, et al. Science 2008 322 587 590 10.1126/science. 1162667 18948540
61. Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. Ishii I, Akahoshi N, Yamada H, Nakano S, Izumi T, Suematsu M, J Biol Chem 2010 285 26358 26368 10.1074/jbc.M110.147439 20566639
62. Nitric Oxide Mechanism of protection in ischemia reperfusion injury. Phillips L, Lopez-Nebllna F, Toledo A, Anaya-Prado R, Toledo-Pereyra p, Invs Surgery 2009 22 46 55 10.1080/08941930802709470
63. Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I, Hepatogastroenterology 2004 51 1404 1407 15362764 (Pubitemid 38987493)
64. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X, Liver Transpl 2009 15 1306 1314 10.1002/lt.21810 19790158
65. The endogenous hydrogen sulfide producing enzyme cystathionine-beta synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome. Xu GY, Winston JH, Shenoy M, Zhou S, Chen JD, Pasricha PJ, Mol Pain 2009 5 44 10.1186/1744-8069-5-44 19660142
66. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. Tripatara P, Patel NS, Webb A, Rathod K, Lecomte FM, Mazzon E, Cuzzocrea S, Yaqoob MM, Ahluwalia A, Thiemermann C, J Am Soc Nephrol 2007 18 570 580 10.1681/ASN.2006050450 17202421 (Pubitemid 46193322)
67. Antioxidative effects of exogenous nitric oxide versus antioxidant vitamins on renal ischemia reperfusion injury. Unal D, Yeni E, Erel O, Bitiren M, Vural H, Urol Res 2002 30 190 194 10.1007/s00240-002-0254-5 12111183 (Pubitemid 36056666)
68. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, et al. Lab Invest 2008 88 1038 1048 10.1038/labinvest.2008.73 18679378
69. Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion. Chen SH, Cheung RT, J Biomed Sci 2005 12 267 278 10.1007/s11373-005-1359-y 15942706 (Pubitemid 40897635)
70. Vascular endothelial growth factor expression in focal cerebral ischemia/reperfusion in injury in rats. Xing Y, Xu ZX, Mang J, Qian JL, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005 17 174 176 15760533
71. Myocardial protection by nitrite. Calvert JW, Lefer DJ, Cardiovasc Res 2009 83 195 203 10.1093/cvr/cvp079 19251721
72. Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Florian B, Vintilescu R, Balseanu AT, Buga AM, Grisk O, Walker LC, Kessler C, Popa-Wagner A, Neurosci Lett 2008 438 180 185 10.1016/j.neulet.2008. 04.020 18456407
73. Hydrogen sulfide is a mediator of cerebral ischemic damage. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT, Stroke 2006 37 889 893 10.1161/01.STR. 0000204184.34946.41 16439695 (Pubitemid 43731927)
74. Engineered pathways for correct disulfide bond oxidation. Ren G, Bardwell J, Antioxid Redox Signal
75. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Kimura Y, Goto Y, Kimura H, Antioxid Redox Signal 2010 12 1 13 10.1089/ars.2008.2282 19852698
76. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F, Circulation 2009 120 888 896 10.1161/CIRCULATIONAHA.108.833491 19704099
77. Heme oxygenase-1/carbon monoxide:from basic science to therapeutic applications. Ryter S, Morse D, Choi A, Antioxid Red Siganl 2010 12 1 13 10.1089/ars.2008.2282
78. Heme oxygenase-1 system in organ transplantation. Katori M, Busuttil RW, Kupiec-Weglinski JW, Transplantation 2002 74 905 912 10.1097/00007890-200210150- 00001 12394829 (Pubitemid 35191234)
79. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza AV, Ollinger R, Czismadia E, May GA, Ifedigbo E, Otterbein LE, et al. FASEB J 2004 18 771 772 14977880
80. Study on the preservation with CO (PCO = 200-2,000 hPa), resuscitation, and heterotopic transplantation of an isolated rat heart. Yoshida Y, Hatayama N, Seki K, Cell Transplant 2009 18 535 540 19775514
81. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, et al. J Immunol 2001 166 4185 4194 11238670 (Pubitemid 32224952)
82. Carbon monoxide inhalation ameliorates conditions of lung grafts from rat brain death donors. Zhou HC, Ding WG, Cui XG, Pan P, Zhang B, Li WZ, Chin Med J (Engl) 2008 121 1411 1419
83. Experiences with leflunomide in solid organ transplantation. Williams JW, Mital D, Chong A, Kottayil A, Millis M, Longstreth J, Huang W, Brady L, Jensik S, Transplantation 2002 73 358 366 10.1097/00007890-200202150-00008 11884931 (Pubitemid 34174284)
84. Cross talk between carbon monoxide and nitric oxide. Hartsfield CL, Antioxid Redox Signal 2002 4 301 307 10.1089/152308602753666352 12006181 (Pubitemid 34517181)
85. Novel neural modulators. Boehning D, Snyder S, Ann Rev Neurosci 2003 26 105 131 10.1146/annurev.neuro.26.041002.131047 14527267 (Pubitemid 37064930)
86. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. Maejima Y, Adachi S, Morikawa K, Ito H, Isobe M, J Mol Cell Cardiol 2005 38 163 174 10.1016/j.yjmcc.2004.10.012 15623433 (Pubitemid 40038663)
87. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Rakhit R, Mojet M, Marber M, Duchen M, Ciruculation 2001 103 2617 2623 (Pubitemid 32521974)
88. Nitric oxide production and signaling in inflammation. Korhonen R, Lahti A, Kankaanranta H, Moilanen E, Curr Drug Targets Inflamm Allergy 2005 4 471 479 10.2174/1568010054526359 16101524 (Pubitemid 41052412)
89. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Wang R, Wang Z, Wu L, Br J Pharmacol 1997 121 927 934 10.1038/sj.bjp.0701222 9222549 (Pubitemid 27277786)
90. The evolution of carbon monoxide into medicine. Otterbein L, Respir Care 2009 54 925 932 10.4187/002013209793800394 19558742
91. Carbon monoxide inhalation decreased lung injury via anti-inflammatory and anti-apoptotic effects in brain death rats. Zhou H, Liu J, Pan P, Jin D, Ding W, Li W, Exp Biol Med (Maywood) 2010 235 1236 1243 10.1258/ebm.2010.010147
92. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H, J Biochem 2009 146 623 626 10.1093/jb/mvp111 19605461
93. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. Wagner CA, J Nephrol 2009 22 173 176 19384833
94. Gasotransmitters in the gastrointestinal tract. Kasparek MS, Linden DR, Kreis ME, Sarr MG, Surgery 2008 143 455 459 10.1016/j.surg.2007.10.017 18374039
95. Carbon monoxide: to boldly go where NO has gone before. Ryter SW, Morse D, Choi AM, Sci STKE 2004 2004 E6 10.1126/stke.2302004re6 15114002
96. Nitric oxide as a secretory product of mammalian cells. Nathan C, FASEB J 1992 6 3051 3064 1381691
97. Targeting heme oxygenase-1 in vascular disease. Durante W, Curr Drug Targets 2010 11 1504 1516 20704550
98. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Li XH, Du JB, Bu DF, Tang XY, Tang CS, Acta Pharmacol Sin 2006 27 971 980 10.1111/j.1745-7254.2006.00353.x 16867247 (Pubitemid 44127904)
99. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Wanstall J, Jeffery T, Gambino A, Lovren F, Triggle C, Br J Pharmaco 2001 134 463 472 10.1038/sj.bjp.0704269 (Pubitemid 32977891)
100. The regulation of carbon monoxide/heme oxygenase system by hydrogen sulfide in rats with hypoxic pulmonary hypertension. Zhang QY, Du JB, Zhang CY, Tang CS, Zhonghua Jie He He Hu Xi Za Zhi 2004 27 659 663 16200866
101. Role of heme oxygenase-1 in the cardioprotective effects of erythorpoietin during myocardial ischemia. Burger D, Xiang H, Lu X, Feng Q, Am J Physiol Heart Circ Physiol 2009 1 84 93